Citation Impact
Citing Papers
Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation
2012
Systematic review with meta‐analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome
2018
Probiotic Effects on Cold and Influenza-Like Symptom Incidence and Duration in Children
2009
Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion
2014
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
2009 Standout
The efficacy of a synbiotic containing Bacillus Coagulans in treatment of irritable bowel syndrome: a randomized placebo-controlled trial.
2014
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome
2009
Microbiota in health and diseases
2022 Standout
Mechanisms Underlying Visceral Hypersensitivity in Irritable Bowel Syndrome
2011
A Klothoβ Variant Mediates Protein Stability and Associates With Colon Transit in Irritable Bowel Syndrome With Diarrhea
2011
A mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome – A randomized controlled trial with primary care physicians
2008
Epidemiology and Natural History of Gastroparesis
2014
American Gastroenterological Association Technical Review on Constipation
2012
Serotonin in the gastrointestinal tract
2009
Current management strategies and emerging treatments for functional dyspepsia
2013
Guidance for Substantiating the Evidence for Beneficial Effects of Probiotics: Probiotics in Chronic Inflammatory Bowel Disease and the Functional Disorder Irritable Bowel Syndrome1–3
2010
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Probiotics as Therapy in Gastroenterology
2010
Bowel Disorders
2016 Standout
Effect of a fermented milk containing Bifidobacterium animalis DN‐173 010 on the health‐related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double‐blind, controlled trial
2007
Meta-analysis of probiotics for the treatment of irritable bowel syndrome
2008
Bowel Functions, Fecal Unconjugated Primary and Secondary Bile Acids, and Colonic Transit in Patients With Irritable Bowel Syndrome
2013
Microbial tryptophan catabolites in health and disease
2018 Standout
Probiotics, Prebiotics, and Synbiotics
2008
Basic and clinical pharmacology of new motility promoting agents
2005
Lessons learned — resolving the enigma of genetic factors in IBS
2016
Effectiveness of Probiotics in the Treatment of Irritable Bowel Syndrome
2008
Lubiprostone Increases Spontaneous Bowel Movement Frequency and Quality of Life in Patients With Chronic Idiopathic Constipation
2014
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics
2020 Standout
Genetic Approaches to Functional Gastrointestinal Disorders
2010
Emerging drugs for irritable bowel syndrome
2006
Serotonin and Its Role in Colonic Function and in Gastrointestinal Disorders
2006
Genetic susceptibility to inflammation and colonic transit in lower functional gastrointestinal disorders: preliminary analysis
2011
CLC Chloride Channels and Transporters: From Genes to Protein Structure, Pathology and Physiology
2008
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
Functional GI disorders: from animal models to drug development
2007
The role of the gut microbiota in nutrition and health
2012 Standout
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society for metabolic & bariatric surgery*
2013 Standout
Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis
2014
Opioid-Induced Constipation: Challenges and Therapeutic Opportunities
2011
British Dietetic Association systematic review of systematic reviews and evidence‐based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update)
2016
New insights into the pathophysiology of irritable bowel syndrome: Implications for future treatments
2005
Review article: the treatment of functional abdominal bloating and distension
2011
The stomach in health and disease
2015
Fecal excretion of Bifidobacterium infantis 35624 and changes in fecal microbiota after eight weeks of oral supplementation with encapsulated probiotic
2013
The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders
2007 Standout
ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease
2013 Standout
Epidemiology of functional constipation and comparison with constipation-predominant irritable bowel syndrome: the Systematic Investigation of Gastrointestinal Diseases in China (SILC)
2011
A randomised clinical trial (RCT) of a symbiotic mixture in patients with irritable bowel syndrome (IBS): effects on symptoms, colonic transit and quality of life
2012
Serotonergic and non‐serotonergic targets in the pharmacotherapy of visceral hypersensitivity
2007
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Irritable bowel syndrome
2016 Standout
Enterococci as probiotics and their implications in food safety
2011 Standout
Efficacy of an Encapsulated Probiotic Bifidobacterium infantis 35624 in Women with Irritable Bowel Syndrome
2006
Health benefits of probiotics: are mixtures more effective than single strains?
2011
British Dietetic Association evidence‐based guidelines for the dietary management of irritable bowel syndrome in adults
2012
Treating irritable bowel syndrome: overview, perspective and future therapies
2004
The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome
2010
Cumulative incidence of chronic constipation: a population‐based study 1988–2003
2007
The Functional Gastrointestinal Disorders and the Rome III Process
2006 Standout
Effects of A3309, an Ileal Bile Acid Transporter Inhibitor, on Colonic Transit and Symptoms in Females With Functional Constipation
2011
Peripheral Mechanisms in Irritable Bowel Syndrome
2012
Update on the management of constipation in the elderly: new treatment options
2010
Probiotics VSL#3 Protect against Development of Visceral Pain in Murine Model of Irritable Bowel Syndrome
2013
Lubiprostone
2006
Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort
2009
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies
2016
Effect of 5 Days Linaclotide on Transit and Bowel Function in Females With Constipation-Predominant Irritable Bowel Syndrome
2007
Systematic review: the efficacy of treatments for irritable bowel syndrome – a European perspective
2006
The Increased Level of Depression and Anxiety in Irritable Bowel Syndrome Patients Compared with Healthy Controls: Systematic Review and Meta-analysis
2017
The Utility of Probiotics in the Treatment of Irritable Bowel Syndrome: A Systematic Review
2009
Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis
2014
The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants
2017 Standout
The role of short-chain fatty acids in microbiota–gut–brain communication
2019 Standout
The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
2014 Standout
Probiotics and Prebiotics in Pediatrics
2010
Activation of Human Enteric Neurons by Supernatants of Colonic Biopsy Specimens From Patients With Irritable Bowel Syndrome
2009
Dysbiosis of the gut microbiota in disease
2015 Standout
Lubiprostone: chronic constipation and irritable bowel syndrome with constipation
2008
Mechanisms of hypersensitivity in IBS and functional disorders
2007
American Gastroenterological Association Institute Technical Review on the Pharmacological Management of Irritable Bowel Syndrome
2014
Manipulation of the Microbiota for Treatment of IBS and IBD—Challenges and Controversies
2014
Influence of diet on the gut microbiome and implications for human health
2017 Standout
Pilot study of the efficacy of renzapride on gastrointestinal motility and symptoms in patients with constipation‐predominant irritable bowel syndrome
2006
Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial
2015 Standout
Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date
2006
Clinical Guideline: Management of Gastroparesis
2012
Efficacy and safety of oral lubiprostone in constipated patients with or without irritable bowel syndrome: a randomized, placebo-controlled and dose-finding study
2011
Efficacy of 5-HT3 Antagonists and 5-HT4 Agonists in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis
2009
Guidelines on the irritable bowel syndrome: mechanisms and practical management
2007
Effect of Increased Bile Acid Synthesis or Fecal Excretion in Irritable Bowel Syndrome-Diarrhea
2014
Systematic review: complementary and alternative medicine in the irritable bowel syndrome
2006
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
The Role of Prebiotics and Probiotics in Gastrointestinal Disease
2017
Update on Irritable Bowel Syndrome and Gender Differences
2008
The Fecal Microbiota of Irritable Bowel Syndrome Patients Differs Significantly From That of Healthy Subjects
2007
Endosome maturation
2011 Standout
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Sensors and regulators of intracellular pH
2009 Standout
Epidemiology and Burden of Chronic Constipation
2011
Increased Risk for Irritable Bowel Syndrome After Acute Diverticulitis
2013
VSL#3 Probiotic Mixture
2006
Probiotics, prebiotics and synbiotics- a review
2015
Efficacy and Safety of Lubiprostone in Patients with Chronic Constipation
2009
Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate
2016
Lubiprostone
2009
The role of probiotics in management of irritable bowel syndrome
2007
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
2012 Standout
Probiotic-induced reduction of gastrointestinal oxalate absorption in healthy subjects
2010
Cannabinoids and the gut: New developments and emerging concepts
2010
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis
2008 Standout
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review
2008
American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation
2014
The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice
2011 Standout
Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren
2010 Standout
The pros, cons, and many unknowns of probiotics
2019 Standout
Multicenter, 4-Week, Double-Blind, Randomized, Placebo-Controlled Trial of Lubiprostone, a Locally-Acting Type-2 Chloride Channel Activator, in Patients With Chronic Constipation
2007
Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double‐blind, placebo‐controlled, dose‐ranging study to evaluate efficacy and safety
2007
Self-Reported Food-Related Gastrointestinal Symptoms in IBS Are Common and Associated With More Severe Symptoms and Reduced Quality of Life
2013 Standout
Intestinal microbiota in functional bowel disorders: a Rome foundation report
2012
Irritable bowel syndrome: towards biomarker identification
2009
Irritable Bowel Syndrome
2015 Standout
Methylnaltrexone for the treatment of opioid-induced constipation
2012
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Neuronal activation by mucosal biopsy supernatants from irritable bowel syndrome patients is linked to visceral sensitivity
2014
Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy
2017
Probiotic Bacteria Influence the Composition and Function of the Intestinal Microbiota
2008
Effects of Probiotics, Prebiotics, and Synbiotics on Human Health
2017 Standout
Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome
2012
Intestinal permeability – a new target for disease prevention and therapy
2014 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
5‐Hydroxytryptamine effects in the gut: the 3, 4, and 7 receptors
2005
Epidemiology and Burden of Chronic Constipation
2011
The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
2018 StandoutScience
Emerging Treatment Options in Mild to Moderate Ulcerative Colitis.
2015
Natural product and natural product derived drugs in clinical trials
2014 Standout
Do interactions between stress and immune responses lead to symptom exacerbations in irritable bowel syndrome?
2011
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice - an evidence-based international guide
2013
The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems.
2015 Standout
Irritable bowel syndrome is associated with novel inflammatory markers derived from hemogram parameters
2020 Standout
Pharmacological Demarcation of the Growth Hormone, Gut Motility and Feeding Effects of Ghrelin Using a Novel Ghrelin Receptor Agonist
2008
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout
Challenges and approaches for production of a healthy and functional mayonnaise sauce
2019 Standout
Probiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It?
2015
Review article: probiotics for the treatment of irritable bowel syndrome – focus on lactic acid bacteria
2012
The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel disease
2020 Standout
Works of Kari Baxter being referenced
Obesity Does Not Increase Effects of Synthetic Ghrelin on Human Gastric Motor Functions
2006
Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study
2007
Dose-response effect of a β3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health
2008
Effect of renzapride on transit in constipation-predominant irritable bowel syndrome
2004
Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo‐controlled study
2006
Prospective Study of Motor, Sensory, Psychologic, and Autonomic Functions in Patients With Irritable Bowel Syndrome
2008
Does co-administration of a non-selective opiate antagonist enhance acceleration of transit by a 5-HT4agonist in constipation-predominant irritable bowel syndrome? A randomized controlled trial
2007
Effect of Alvimopan and Codeine on Gastrointestinal Transit: A Randomized Controlled Study
2005
A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating
2005
Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation
2007
Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers
2006
Candidate genes and sensory functions in health and irritable bowel syndrome
2008
Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women
2006
Gastric Sensorimotor Functions and Hormone Profile in Normal Weight, Overweight, and Obese People
2006
A Stable Isotope Breath Test With a Standard Meal for Abnormal Gastric Emptying of Solids in the Clinic and in Research
2008
An exploratory study of the association of adrenergic and serotonergic genotype and gastrointestinal motor functions
2007
Pharmacogenetics of low dose clonidine in irritable bowel syndrome
2009
Effect of Gastric Volume or Emptying on Meal-Related Symptoms After Liquid Nutrients in Obesity: A Pharmacologic Study
2005
W1333 Candidate Adrenergic, Gnβ3 and Serotonergic Polymorphisms, Endophenotype, Pharmacogenetics of Clonidine in Irritable Bowel Syndrome and Health
2008